Tuesday, November 14, 2017, Fairmont San Jose
170 S Market St, San Jose, CA 95113

CMS Rule on Diabetes Prevention a Missed Opportunity That Puts Seniors at Risk - AJMC.com Managed Markets Network

 
 
AJMC.com Managed Markets NetworkCMS Rule on Diabetes Prevention a Missed Opportunity That Puts Seniors at RiskAJMC.com Managed Markets NetworkNoom applauds CMS for taking the important step of proposing a rule for the Medicare Diabetes Prevention Program (DPP). However, not including virtual providers of the DPP in the proposed rule leaves millions of seniors at risk and will cost the ...
 
Related NewsFeeds

Yahoo NewsRXi Pharmaceuticals' sd-rxRNA: Better delivery than Amazon!Yahoo NewsRXi Pharmaceuticals Corporation ( RXII) is a unique player in the RNAi space due to the inherent self-delivery mechan

0 visits

BloombergPfizer Channels Its Inner BiotechBloombergIn keeping with a trend of smaller firms raising buckets of cash using Big Pharma's cast-off drugs, Pfizer Inc. is adapting the strategy for itse

1 visits

Bone density, microstructure deficits found in type 2 diabetesHealioResearchers identified deficits in bone microstructure and volumetric bone density at the distal tibia and distal radius in adults w

1 visits

Seeking AlphaAlnylam And Sanofi Achieve An RNAi FirstSeeking AlphaCompetition from Ionis Pharmaceuticals should be monitored closely. Safety will play a key role in whether or not patisiran will be ap

0 visits

Why Valeant Pharmaceuticals (VRX) Stock is Still no BargainInvestorplace.comMost of us have heard of Valeant Pharmaceuticals Intl Inc (NYSE:VRX). VRX stock infamously went from approximately $260 per

0 visits

Visualize: What would these 8 biotech companies look like without immigrants?Endpoints NewsSeveral biotech colleagues and I were inspired by the Neuroscience Lab at Cold Spring Harbor's clever and

0 visits

Fresenius Kabi starts work on $250m US sterile drug plantIn-PharmaTechnologist.comFresenius Kabi execs Steve Nowicki, Dr. Michael Schoenhofen and John Ducker join Mayor Ron Serpico of Melrose Park, Il

0 visits

SalvaRx, Immunova establish new JV firm Saugatuck TherapeuticsPharmaceutical Business ReviewSalvaRx has signed an agreement with Immunova to create a new joint venture (JV) firm Saugatuck Therapeutics

0 visits

Green Valley NewsDrugs & Genes: Pharmacogenomics for the Modern Health Care TeamGreen Valley NewsPharmacogenomics (PGx), the study of how one's genes may affect an individual's response to med

0 visits

Medical XpressScientists first to use genetic engineering technique to investigate Tourette'sMedical XpressTischfield, and doctoral student Nawei Sun, and their colleagues, converted blood cells o

0 visits

Biotech Forum Daily Digest: Recro Pharma On The MoveSeeking AlphaThe biotech sector continues to trade in a tight range here in September while digesting the big gains from late August. Madrigal Pharm

0 visits

UGA TodayThe rat race is over: New livestock model for stroke could speed discoveryUGA TodayAssociate Professor Franklin West and Emily Baker working with induced pluripotent stem cells generated from

0 visits

The top 5 trends in biotech - #3: High valuations for attractive biotechs are a durable symptom of a thriving ...Endpoints NewsIt's been interesting watching the various big biopharma players exec

0 visits

Diabetes Overtreated In Medicare PatientsManaged Care magazineFirst, the grain of salt. The American Geriatrics Society began recommending less aggressive treatment for diabetes in 2013. So, according

0 visits

Rhythm Pharmaceuticals' IPO to raise up to $106.7 millionMarketWatchRhythm Pharmaceuticals Inc. rytm, +0.00% said Monday that it was offering 6.67 million shares of common stock for sale in its in

0 visits

TheStreet.comIntercept Spikes on Positive Liver Disease Data: Novocure Jumps -Biotech MoversTheStreet.comIntercept Spikes on Positive Liver Disease Data: Novocure Jumps -Biotech Movers. The St. Helier

0 visits

EurekAlert (press release)Regenerating tissues with gene-targeting moleculesEurekAlert (press release)Human induced pluripotent stem cells (hiPSCs) are generated from adult cells and can be programmed

0 visits

The Daily Herald'The future is biotech,' but for now he's busy with everythingThe Daily HeraldNathan Nicholson, 17, is a senior at Snohomish High School, where he keeps very busy running s

0 visits

Smarter AnalystIntercept Pharmaceuticals Stock Overreacts To Company Communiqué, Presents Buy OpportunitySeeking AlphaIntercept Pharmaceuticals Inc. (NASDAQ:ICPT) stock suffered another setback as the

0 visits

Simply Wall StStock Volatility Risk Alert: China Biologic Products Inc Stock Volatility Hits An Elevated LevelCML NewsBefore we cover the full analysis we make a quick alert here that China Biologic P

0 visits